HETEROARYL COMPOUNDS AS LIGAND DIRECTED DEGRADERS OF IRAK4
Provided herein are compounds and compositions thereof for modulating IRAK4. In some embodiments, the compounds and compositions are provided for treatment of inflammatory or autoimmune diseases..
Medienart: |
Patent |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Europäisches Patentamt - (2024) vom: 25. Jan. Zur Gesamtaufnahme - year:2024 |
---|
Sprache: |
Englisch |
---|
Beteiligte Personen: |
RASMUSSON TIMOTHY [VerfasserIn] |
---|
Links: |
Volltext [kostenfrei] |
---|
Anmerkungen: |
Source: www.epo.org (no modifications made), First posted: 2024-01-25, Last update posted on www.tib.eu: 2024-02-07, Last updated: 2024-02-09 |
---|
Patentnummer: |
WO2024020084 |
---|
Förderinstitution / Projekttitel: |
|
---|
PPN (Katalog-ID): |
EPA019157894 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | EPA019157894 | ||
003 | DE-627 | ||
005 | 20240209083327.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240209s2024 xx |||||o 00| ||eng c | ||
035 | |a (DE-627)EPA019157894 | ||
035 | |a (EPA)WO2024020084 | ||
035 | |a (EPA)87571763 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 0 | |a RASMUSSON TIMOTHY |e verfasserin |4 aut | |
245 | 1 | 0 | |a HETEROARYL COMPOUNDS AS LIGAND DIRECTED DEGRADERS OF IRAK4 |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Source: www.epo.org (no modifications made), First posted: 2024-01-25, Last update posted on www.tib.eu: 2024-02-07, Last updated: 2024-02-09 | ||
520 | |a Provided herein are compounds and compositions thereof for modulating IRAK4. In some embodiments, the compounds and compositions are provided for treatment of inflammatory or autoimmune diseases. | ||
650 | 4 | |a C07D: Heterocyclic compounds (macromolecular compounds c08) | |
650 | 4 | |a A61K: Preparations for medical, dental, or toilet purposes (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms a61j0003000000;chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles a61l; soap compositions c11d) | |
650 | 4 | |a A61P: Specific therapeutic activity of chemical compounds or medicinal preparations | |
650 | 4 | |a che | |
650 | 4 | |a 615 | |
700 | 0 | |a DAVIES GERAINT |4 aut | |
700 | 0 | |a GORMISKY PAUL |4 aut | |
700 | 0 | |a MA RULIN |4 aut | |
700 | 0 | |a ELLIS JOHN MICHAEL |4 aut | |
700 | 0 | |a HU LINGBOWEI |4 aut | |
700 | 0 | |a SIU TONY |4 aut | |
700 | 0 | |a VAN DER MEI FARID |4 aut | |
700 | 0 | |a HAGER HARRY |4 aut | |
700 | 0 | |a MENG YILIN |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Europäisches Patentamt |g (2024) vom: 25. Jan. |
773 | 1 | 8 | |g year:2024 |g day:25 |g month:01 |
856 | 4 | 0 | |u https://worldwide.espacenet.com/patent/search/family/87571763/publication/WO2024020084A1?q=WO2024020084 |z kostenfrei |3 Volltext |
912 | |a GBV_EPA | ||
936 | u | w | |j 2024 |b 25 |c 01 |
951 | |a AR | ||
952 | |j 2024 |b 25 |c 01 |